SCHEMBL20834652

SCHEMBL20834652

c1ccc(-c2cccc(-c3[nH]nc4ccccc34)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
ALK Q9UM73 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
ASIC3 Q9UHC3 1/20 0.42
NOS1 P29475 1/20 0.42
ACHE P22303 1/20 0.41
ELANE P08246 1/20 0.40
GRM5 P41594 1/20 0.40
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 3/20 0.38
PDE10A Q9Y233 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TGFBR1 P36897 1/20 0.38
ILK Q13418 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12075154 0.91 CYP1A2 (0.48) RAB9AMEN1KMT2ACYP1A2CYP2C19
SCHEMBL12286155 0.80 CYP1A2 (0.52) RAB9AALKCYP1A2CYP2C19NOS1
SCHEMBL17196524 0.77 CYP1A2 (0.48) RAB9AALKCYP1A2CYP2C19NOS1
SCHEMBL58442 0.73 MEN1 (1.00) RAB9AMEN1KMT2AASIC3LMNA
SCHEMBL16077969 0.71 MEN1 (0.94) RAB9AMEN1KMT2AASIC3LMNA
SCHEMBL4406097 0.71 MEN1 (0.94) RAB9AMEN1KMT2AASIC3LMNA
Bromide SCHEMBL10753629 0.71 MEN1 (0.94) RAB9AMEN1KMT2AASIC3LMNA
SCHEMBL5945940 0.71 MEN1 (0.94) RAB9AMEN1KMT2AASIC3LMNA
SCHEMBL12345158 0.70 MEN1 (0.73) RAB9AMEN1KMT2AASIC3ACHE
SCHEMBL23869334 0.69 MEN1 (0.80) RAB9AMEN1KMT2AASIC3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190088889-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190088889-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES TIMCC, ICOSLG, NUDT1 RAB9A 3729/4885MEN1 2825/4885KMT2A 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.